---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-000990"
form_type: "8-K"
ticker: "EYPT"
cik: "0001314102"
company_name: "EyePoint, Inc."
filed_at: "2023-01-23T23:59:59+00:00"
generated_at: "2026-06-20T11:34:28.260739+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# EyePoint signs lease for 40,000 sq ft manufacturing facility; rent starts H2 2024

## Summary
- Lease for build-to-suit cGMP facility in Northbridge, MA to support EYP-1901 and YUTIQ manufacturing.
- Annual base rent ~$2.44M ($61/sq ft), escalating to ~$3M over 15-year initial term; total ~$41M.
- Rent commences in H2 2024 after construction; facility expected operational in H2 2024.
- Awarded $1.9M in state and local tax incentives as part of the agreement.
- Two renewal options (5 or 10 years) at 95% of fair market rent; expansion right up to 20,000 sq ft.

## SEC filing metadata
- accession: 0000950170-23-000990
- form_type: 8-K
- ticker: EYPT
- cik: 0001314102
- company_name: EyePoint, Inc.
- filed_at: 2023-01-23T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1314102/000095017023000990/0000950170-23-000990-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1314102/000095017023000990/eypt-20230123.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-000990
- JSON: https://secwatch.observer/filing/0000950170-23-000990.json
- Plain text: https://secwatch.observer/filing/0000950170-23-000990.txt

## Key facts
- Material Agreements
  EyePoint, Inc. entered into Lease with V.E. Properties IX, LLC valued at approximately $41 million (effective 2023-01-23).
  - Action: entry
  - Agreement: lease
  - Counterparty: V.E. Properties IX, LLC
  - Value: approximately $41 million
  - Effective: 2023-01-23
  source text: On January 23, 2023, EyePoint Pharmaceuticals, Inc. (the “Company”) and V.E. Properties IX, LLC (the “Landlord”) entered into a lease agreement (the “Lease”) relating to the lease by the Company of a to-be-constructed build-to-suit stand-alone commercial manufacturing facility
  evidence_url: https://www.sec.gov/Archives/edgar/data/1314102/000095017023000990/0000950170-23-000990-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.